Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: Results from a population-based cohort

Keyphrases

• Population-based Cohort 100%
• Cell Cycle Genes 100%
• Breast Cancer Survival 100%
• Germline Genetic Variation 100%
• CCND3 100%
• Polymorphism 66%
• Rare Allele 66%
• Single nucleotide Polymorphism 33%
• In Cancer 33%
• Genotype 33%
• Genetic Variation 33%
• Breast Tumor 33%
• Risk Factors 33%
• Hazard Ratio 33%
• Epidemiology 33%
• Cell Division 33%
• Microarray Data 33%
• Minor Allele Frequency 33%
• Invasive Breast Cancer 33%
• Cyclin D1 (CCND1) 33%
• Cyclin-dependent Kinase Inhibitor 2A (CDKN2A) 33%
• Cyclin-dependent Kinase 4 (CDK4) 33%
• CCNE1 33%
• Biological Interest 33%
• Cox Regression Analysis 33%
• Cyclin-dependent Kinase 6 (CDK6) 33%
• Tumor Stage 33%
• Tumor Grade 33%
• Mortality Hazard 33%
• CDKN1A 33%
• Risk of Death 33%
• Linkage Disequilibrium 33%
• Somatic Alterations 33%
• Tag Single nucleotide Polymorphism (tSNP) 33%
• Expression Microarray 33%
• Tumor Treatment 33%
• Heredity 33%
• Cell Cycle Control 33%
• P27Kip1 33%
• Cell Cycle Pathway 33%
• Cyclin D2 (CCND2) 33%
• Breast Cancer Diagnosis 33%
• CDKN1B 33%
• CDKN2B 33%
• Breast Cancer Prognosis 33%
• Cyclin-dependent Kinase 2 (CDK2) 33%
• 95% Confidence Interval 33%
• USP49 33%
• P21Cip1 33%
• Common Polymorphisms 33%
• CDKN2D 33%
• Breast Cancer Study 33%
• Somatic Expression 33%
• FRS3 33%
• CDKN2C 33%

Biochemistry, Genetics and Molecular Biology

• Genetic Divergence 100%
• Germline 100%
• Germ Cell 100%
• Genetic Variation 100%
• Cell Cycle Regulation 100%
• Cancer Survival 100%
• Allele 66%
• Single-Nucleotide Polymorphism 66%
• Cell Cycle 33%
• Cell Division 33%
• Minor Allele Frequency 33%
• P21 33%
• P16 33%
• Cancer Staging 33%
• Cyclin-Dependent Kinase 33%
• Gene Linkage Disequilibrium 33%
• CDKN1B 33%
• Cyclin Dependent Kinase Inhibitor 2A 33%
• Microarray Data 33%
• CDKN2C 33%
• CDKN2B 33%